EC-MPS, MMF Similar in Efficacy in Tacrolimus-Treated Transplant PatientsRenal and Urology News… showed that patients treated with EC-MPS or MMF had no significant differences with respect to concomitant immunosuppression, the incidence of biopsy-pro…
Warning Label Urged for St. John's WortCSPI Newsroom… former FDA Commissioner Jane E. Henney warned that St. John's wort “interacts with many drugs that are used to treat heart disease, depression, seizures, certain cancers, as well as drug…
Merck Rewards Shareholders with First Dividend Increase in 7 YearsWall St. Cheat SheetThe Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection a…
Veloxis Pharmaceuticals Presents LCP-Tacro(TM) Phase 3 Data at the American …MarketWatch (press release)The results presented today show that LCP-Tacro(TM) once-daily was associated with a trend towards reduction in the incidence of Biopsy Proven Acu…
Top Healthcare Stock Holdings in Sterne Agee's Latest 13FWall St. Cheat SheetThe Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and ps…
Photopheresis Is The Fastest Expanding Sector Of The Therapeutic Apheresis MarketOfficialWire (press release)The strong growth in photopheresis is attributable to its growing demand in off-label indications such as the prevention of solid organ transpl…
NASDAQ Volume Active Stocks are – INCY, PSUN, ALXN, VSEA, BSFTRetirement Planning… development and commercialization of therapeutic products aimed at treating patients with severe and life-threatening disease states, including those in the therapeuti…
Bristol-Myers Squibb (BMY) Crosses Pivot Point Support at $31.45Financial News Network OnlineThe Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant reje…
EON: Enhanced Online News (press release)XDx Announces Highmark's Coverage of AlloMap® for Monitoring Heart Transplant …EON: Enhanced Online News (press release)Highmark considers AlloMap “medically necessary” for monitoring heart transplant…
Healthcare Sector: New Share Price Targets IssuedWall St. Cheat SheetThe Company's products treat autoimmune diseases, cardiovascular diseases, cancer, and inflammation, as well as infectious diseases and organ transplant rejection. Get the most re…